Latest Blog Posts Tagged "Alzheimers"
July 29, 2015
Drugs in development that go after the processes, rather than the proteins, involved in Alzheimer's onset may have potential to treat Parkinson's disease, as well.
March 23, 2015
Pharmaceutical company Biogen last week shared positive results from its study of a drug to slow Alzheimer's progression. These findings have implications for Parkinson's research, as well.
June 10, 2014
The same company that MJFF has funded for a clinical trial of a Parkinson's disease-modifying drug announces positive results from a study of its drug to slow Alzheimer's.
May 28, 2014
David Irwin, MD, from the University of Pennsylvania, answers questions from our last Webinar on the overlap between Alzheimer's and Parkinson's diseases.
May 06, 2014
Mark Frasier, PhD, VP of research programs at MJFF, discusses what we know about the overlap between Alzheimer's and Parkinson's diseases.
April 24, 2014
Michael Kinsley, who was diagnosed with Parkinson's 20 years ago, writes in The New Yorker about the cognitive symptoms of the disease.
October 14, 2013
In more news from the frontier of smell and your brain, USA Today reports that peanut butter may have particular power to help researchers predict Alzheimer's disease, or confirm a diagnosis.
September 23, 2013
Last week the National Institute on Aging announced a $33-million grant to an Alzheimer's disease clinical trial that will study people at the greatest genetic risk for developing the disease.
March 14, 2013
The FDA plans to make it easier to get novel Alzheimer's drugs approved for market, news that could also have ramifications for treatments targeting cognitive decline in PD.
November 13, 2012
Over the past few months, one particular Alzheimer's disease (AD) drug target has repeatedly been in the news for all the wrong reasons: a protein called beta amyloid.